High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects - Sorbonne Université Access content directly
Journal Articles Revue Neurologique Year : 2022

High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects

Nicolas Villain
  • Function : Author
  • PersonId : 1133683
V. Planche
  • Function : Author
R. Levy
  • Function : Author
Fichier principal
Vignette du fichier
Villain2022_Part1.pdf (1.71 Mo) Télécharger le fichier
Origin Publisher files allowed on an open archive

Dates and versions

hal-03797247 , version 1 (04-10-2022)

Identifiers

Cite

Nicolas Villain, V. Planche, R. Levy. High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects. Revue Neurologique, 2022, ⟨10.1016/j.neurol.2022.06.012⟩. ⟨hal-03797247⟩
5 View
169 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More